Dear group, The hospitals we serve as a Flow Cytometry reference laboratory seem to have some issues regarding Medicare reimbursement due to the ICD9 code being used. The scenario is a follows: The flow lab receives a lymph node with the suspected diagnosis of r/o lymphoma. The lab does the analysis but finds no evidence of a lymphoproliferative disorder. If the hospital (or whoever is asking to be reimbursed) uses the "correct" ICD9 code of lymphadenopathy, they don't get reimbursed (since the code is not part of the LMRP. If they use the Suspected diagnosis code (lymphoma), this could be construed as a false claim. One of our pathologists is in the process of writing to the Fiscal Intermediary to include lymphadenopathy and enlarged lymph nodes as an acceptable diagnosis added to the LMRP. Another problem area is also when we get a bone marrow "for flow" (the kind of see-what-you-can-find type of thing). Which code do we use when we don't find anything malignant and still would like to get reimbursed? Any thoughts or insights from the billing experts on this issue are much appreciated. Thank you - Andrea Illingworth, MS Dahl-Chase Dx Services - Flow Cytometry 333 State Street Bangor, Maine 04401
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:25:56 EST